Merck has struck a $5.7bn deal to buy Terns Pharmaceuticals, a US biotech developing treatments for a rare form of blood and ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...

A new technique called "growing implant" is emerging as an important option in the treatment of bone cancer among children, allowing doctors to adjust the length of an affected limb as the child grows ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...

(HealthDay News) — For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 ...

Am J Health Syst Pharm. 2006;63(5):419-430. During resorption, growth factors and proteins released from osteoblast precursors and bone stimulate the differentiation, chemotaxis, and proliferation of ...

While we’re still far away from finding an actual cure for cancer, it’s undeniable that the world has made progress in ...